These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13908015)

  • 1. [Diabetes and eleparon. Preliminary report on clinical observations].
    HOEHNE HW
    Ther Ggw; 1961 Oct; 100():521-4. PubMed ID: 13908015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of filiform keratitis with eleparon eyedrops].
    STARK H
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1961 Dec; 139():664-7. PubMed ID: 13916313
    [No Abstract]   [Full Text] [Related]  

  • 3. [First experimental and clinical experiences with eleparon in depot form].
    KOESTLER H
    Med Klin; 1960 Apr; 55():553-4. PubMed ID: 14410483
    [No Abstract]   [Full Text] [Related]  

  • 4. [On further experiences with eleparon in obstetrics. Part 2].
    NIEL W
    Med Klin; 1960 Feb; 55():233-4. PubMed ID: 14427075
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with Eleparon, a new heparin body].
    MORAWETZ F; SCHNETZ E
    Wien Med Wochenschr; 1962 Apr; 112():300-4. PubMed ID: 14475822
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE EFFECT OF ELEPARON IN INTRA-ARTICULAR ADMINISTRATION].
    VIERNSTEIN K
    Med Klin; 1964 Feb; 59():305-9. PubMed ID: 14140197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with the immediately acting anticoagulant eleparon in obstetrics].
    NIEL W
    Med Klin; 1959 Jun; 54(26):1209-10. PubMed ID: 13673968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of heparin, heparin derivatives and heparinoids on blood sugar levels of diabetes mellitus patients].
    Bozadzhieva EK; Markovski SG
    Probl Endokrinol (Mosk); 1978; 24(6):23-30. PubMed ID: 82965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary report on effect of chondroitin sulfate to diabetic retinopathia].
    MIYAMURA A; KANEKO K; NISHIZUKA M; NAKAI Y
    Nihon Ganka Kiyo; 1961 Dec; 12():1073-5. PubMed ID: 14474820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Xanthomata tuberosa papulosa generalisata with hyperlipidemia in diabetes mellitus: modification of the skin picture by heparin].
    WALTHER H
    Arch Klin Exp Dermatol; 1960; 211():378-81. PubMed ID: 13842744
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypoglycemic sulfonamides and heparin in the treatment of diabetic pulmonary tuberculous patients].
    de REN ; MEYER D; SIMON G
    Concours Med; 1962 Feb; 84():965-71. PubMed ID: 14491435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 13. New treatment options for heparin-induced thrombocytopenia.
    Ortel TL; Chong BH
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of a resorbable biological matrix in periodontal surgery: clinical observations of 230 cases].
    Roussille G; Barthet B; Serrano P
    Rev Odontostomatol (Paris); 1991; 20(2):129-38. PubMed ID: 1947587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.
    Elalamy I; Lecrubier C; Potevin F; Abdelouahed M; Bara L; Marie JP; Samama M
    Thromb Haemost; 1995 Nov; 74(5):1384-5. PubMed ID: 8607131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danaparoid is not a low-molecular-weight heparin.
    Nicholson CD; Meuleman DG; Magnani HN; Egberts JF; Leibowitz DA; Spinler SA; Cziraky MJ
    Am J Hosp Pharm; 1994 Aug; 51(16):2049-50. PubMed ID: 7526686
    [No Abstract]   [Full Text] [Related]  

  • 19. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.